The main differences between bipolar 1 and bipolar 2 are the severity of manic episodes, and whether or not someone ...
Bipolar disorder affects about 4% of the US population and causes symptoms like depression, fatigue, impulsivity, and periods of high energy.
From ketamine for treatment-resistant bipolar depression to the hazards of bright light at night, here are 5 advances in ...
The Walsh Research Institute (WRI) announces a major scientific breakthrough in understanding bipolar disorder, revealed in The Essence of Bipolar Disorder by William J. Walsh, Ph.D. (Skyhorse ...
GlobalData on MSN
FDA approves Teva and Medincell’s bipolar I disorder treatment
Teva Pharmaceuticals and Medincell have gained approval from the US Food and Drug Administration (FDA) for Uzedy (risperidone ...
This is a developing news story. Please check back soon for updates. The FDA approved extended-release Uzedy for the ...
After single-blind placebo run-in periods of ≤7 days, patients were randomly assigned to 3 weeks of sublingual asenapine (10 mg twice daily [BID] on day 1, flexible-dose 5 or 10 mg BID thereafter), ...
Dr. Calabrese answers the question: 'When Can I Stop Taking Bipolar Meds?' — -- Question: How long do I have to take medication for bipolar disorder, and can I stop if I no longer have symptoms?
FDA approves UZEDY® (risperidone) extended-release injectable suspension for subcutaneous use as monotherapy or as adjunctive ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈